Discover how MedPharm’s end-to-end CDMO model supports topical semisolid and liquid drug development from early-stage formulation through commercial manufacturing. Explore how integrating formulation development, IVRT/IVPT testing, analytical services, stability studies, and GMP manufacturing within one organization helps maintain scientific continuity, reduce development risks, and streamline the path to commercialization.
